Outcome of liver transplantation for drug-induced acute liver failure in the United States: Analysis of the United Network for Organ Sharing database

Liver Transplantation

Volumn 15, Issue 7, 2009, Pages 719-729

  Mindikoglu, Ayse L ^a   Magder, Laurence S ^a   Regev, Arie ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; AZATHIOPRINE; BILIRUBIN; DISULFIRAM; HALOTHANE; HERBACEOUS AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHOTREXATE; METHYLDOPA; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; SERUM ALBUMIN; TUBERCULOSTATIC AGENT; VALPROIC ACID;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CHILD; CREATININE BLOOD LEVEL; DATA BASE; DIALYSIS; DISEASE SEVERITY; ETHNICITY; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORGAN DONOR; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTHROMBIN TIME; SEX DIFFERENCE; SURVIVAL RATE; UNITED STATES;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; HUMANS; INFANT; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; TISSUE AND ORGAN PROCUREMENT; TREATMENT OUTCOME; UNITED STATES; WAITING LISTS;

EID: 68349141269     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21692     Document Type: Article

References (21)

1. Andrade RJ, Lucena MI, Fernández MC, Pelaez G, Pachkoria K, García-Ruiz E, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 2005;129: 512-521.
2. Larrey D, Pageaux GP. Drug-induced acute liver failure. Eur J Gastroenterol Hepatol 2005;17:141-143.
3. Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: Summary of a workshop. Hepatology 2008;47:1401-1415.
4. Russo MW, Galanko JA, Shrestha R, Fried MW, Watkins P. Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl 2004; 10:1018-1023.
5. Björnsson E, Jerlstad P, Bergqvist A, Olsson R. Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden. Scand J Gastroenterol 2005; 40:1095-1101.
6. Polson J. Assessment of prognosis in acute liver failure. Semin Liver Dis 2008;28:218-225.
7. Data collection forms. Available at: http://www.unos.org/data/about/ collection.asp. Accessed October 2008.
8. Raskind JY, El-Chaar GM. The role of carnitine supplementation during valproic acid therapy. Ann Pharmacother 2000;34:630-638.
9. Russell S. Carnitine as an antidote for acute valproate toxicity in children. Curr Opin Pediatr 2007;19:206-210.
10. Blakely P, McDonald BR. Acute renal failure due to acetaminophen ingestion: a case report and review of the literature. J Am Soc Nephrol 1995;6:48-53.
11. Afonso RC, Hidalgo R, Zurstrassen MP, Fonseca LE, Pandullo FL, Rezende MB, et al. Impact of renal failure on liver transplantation survival. Transplant Proc 2008;40:808-810.
12. Baliga P, Merion RM, Turcotte JG, Ham JM, Henley KS, Lucey MR, et al. Preoperative risk factor assessment in liver transplantation. Surgery 1992;112:704-710; discussion 710-711.
13. Cuervas-Mons V, Millan I, Gavaler JS, Starzl TE, Van Thiel DH. Prognostic value of preoperatively obtained clinical and laboratory data in predicting survival following orthotopic liver transplantation. Hepatology 1986;6:922-927.
14. Faenza S, Santoro A, Mancini E, Pareschi S, Siniscalchi A, Zanzani C, Pinna AD. Acute renal failure requiring renal replacement therapy after orthotopic liver transplantation. Transplant Proc 2006;38:1141-1142.
15. Nair S, Verma S, Thuluvath PJ. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 2002;35:1179-1185.
16. Mindikoglu AL, Regev A, Magder LS. Impact of human immunodeficiency virus on survival after liver transplantation: analysis of United Network for Organ Sharing database. Transplantation 2008;85:359-368.
17. Shapiro MA, Lewis JH. Causality assessment of drug-induced hepatotoxicity: promises and pitfalls. Clin Liver Dis 2007;11:477-505.
18. Benichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol 1990;11:272-276.
19. Bjornsson E, Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology 2005;42: 481-489.
20. Danan G, Benichou C. Causality assessment of adverse reactions to drugs - I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993;46: 1323-1330.
21. Kaplowitz N. Drug-induced liver injury. Clin Infect Dis 2004;38(suppl 2):S44-S48.